ALISE REICIN

CIK 1757533 · Chief Executive Officer · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.28M

Companies

4

Total Filings

27

Lifetime Open-Market Net

$105.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SANA Director $2.68 $0 8 2026-06-05
TECX Chief Executive Officer 438,577 $30.28 $13.28M $105.5K 9 2026-03-05
Q32 Bio Inc. (FIXX) Delisted Director $16.82 $0 5 2023-06-15
CELGENE CORP /DE/ (CELGZ) Delisted PRES., GLOBAL CLINICAL DEV. 0 $0 4 2019-11-22

Recent Filings · Page 2 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-12-06 TECX Grant (A) +11,717 $0 EDGAR
2024-07-15 SANA Grant (A) $0 EDGAR
2024-06-24 Grant (A) +291,110 $0
2024-06-07 SANA Grant (A) $0 EDGAR
2023-06-15 Q32 Bio Inc. (FIXX) Delisted Grant (A) $0 EDGAR
2023-06-09 SANA Grant (A) $0 EDGAR
2022-06-17 Q32 Bio Inc. (FIXX) Delisted Grant (A) $0 EDGAR
2022-06-08 SANA Grant (A) $0 EDGAR
2021-06-22 Q32 Bio Inc. (FIXX) Delisted Grant (A) $0 EDGAR
2021-02-18 SANA Grant (A) $0 EDGAR
Showing 1120 of 27
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.